Briggs Morrison, President, Head of R&D at Syndax Pharmaceuticals Inc (SNDX), sold 404,420 shares at $23.22 ($9.5M) on 2022-09-16, disclosed to the SEC on 2022-09-16.
Open-market sale of $9.5M SNDX by President, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.80 | 87,645 | $2.1M | 21.9% |
| 2 | $24.20 | 66,775 | $1.6M | 17.0% |
| 3 | $23.22 | 53,034 | $1.2M | 13.0% |
| 4 | $23.22 | 53,034 | $1.2M | 13.0% |
| 5 | $23.22 | 71,966 | $1.7M | 17.6% |
| 6 | $23.22 | 71,966 |
| $1.7M |
| 17.6% |
| Total | $23.51 avg | 404,420 | $9.5M | 100% |
| Filing → |
| SNDX | SELL | 2023-08-10 | $1.9M | — | Filing → |
| SNDX | SELL | 2023-07-11 | $1.1M | — | Filing → |
| SNDX | SELL | 2023-06-09 | $2.2M | — | Filing → |